arrow
G

Gary H. Lyman

Fred Hutchinson Cancer Center
H指数:128
被引数:7.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Drug development for major chronic health conditions-aligning with growing public health needs: Proceedings from a multistakeholder think tank
2024-04-014
PRE
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

乳腺癌和新型冠状病毒肺炎患者的临床特征,种族不平等和结局: 新型冠状病毒肺炎和癌症联盟 (CCC19) 队列研究

2023-10-172
OA
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma

新型冠状病毒肺炎对活跃的黑色素瘤治疗和有黑色素瘤病史的患者的影响

2023-03-232
OAAI
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice

美国国家癌症研究所联合治疗平台试验与治疗选择的分子分析

2023-01-2026
OAAI
Characterization of older adults with cancer seeking acute emergency department care: A prospective observational study
2022-09-011
OA
Hematopoietic Growth Factors, Version 1.2022 Featured Updates to the NCCN Guidelines
2022-05-0134
OA
Patients Recently Treated for B-lymphoid MalignanciesShow Increased Risk of Severe COVID-19

最近接受B淋巴恶性肿瘤治疗的患者出现严重新型冠状病毒肺炎的风险增加

2022-03-0913
OA
Final survival analysis of a phase 3 study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2-positive early or locally advanced breast cancer
2022-02-150
PRE
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

癌症和新型冠状病毒肺炎患者的合并感染: 新型冠状病毒肺炎和癌症协会 (CCC19) 研究

2022-02-149
OAAI
Observation unit use among patients with cancer following emergency department visits: Results of a multicenter prospective cohort from CONCERN
2021-12-043
OAAI
How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
2021-11-1811
OAAI